Table 3.
Comparison of MHD patients and medical staff suspected of COVID-19 before and after the quarantine period
| Parameters | Before quarantine | After quarantine |
|---|---|---|
| MHD patients, n | n = 46 | n = 44 |
| Clinical symptoms | ||
| Related clinical symptoms*, n (%) | 6 (13.0) | 0 (0) |
| No obvious symptoms, n (%) | 40 (87.0) | 44 (100) |
| Laboratory findings | ||
| White blood cell count, median (IQR), 109/L | 6.3 (5.2–7.1) | 5.7 (4.5–7.5) |
| Neutrophil ratio, median (IQR), % | 73.0 (68.1–78.3) | 67.7 (61.6–77.1) |
| Neutrophil count, median (IQR), 109/L | 4.5 (3.7–5.0) | 4.0 (2.9–5.8) |
| Lymphocyte ratio, mean (SD), % | 14.9 (5.5) | 18.8 (8.0) |
| Lymphocyte count, median (IQR), 109/L | 0.9 (0.6–1.2) | 1.1 (0.8–1.2) |
| Monocyte ratio, median (IQR), % | 7.7 (6.7–9.3) | 8.1 (6.9–9.8) |
| Monocyte count, median (IQR), 109/L | 0.5 (0.4–0.6) | 0.5 (0.4–0.6) |
| Hemoglobin, mean (SD), g/L | 112.7 (20.4) | 106.4 (16.9) |
| Platelet, mean (SD), 109/L | 172.5 (52.6) | 182.4 (65.2) |
| Outcome | ||
| MHD patients | ||
| Critical patients, n (%) | 7 (15.2) | 0 |
| Cure, n (%) | − | 44 (95.7) |
| Death, n (%) | − | 2 (4.3) |
| Medical staff, n | n = 63 | n = 63 |
| Staff with COVID-19, n (%) | 6 (9.5) | 0 |
| Cure, n (%) | 0 | 6 (9.5) |
| Death, n (%) | 0 | 0 |
Values are expressed as mean (standard deviation), median (25th–75th percentile) or n (%). COVID-19, coronavirus disease 2019; CT, computed tomography; IQR, interquartile range; SD, standard deviation; * Related clinical symptoms: fever, fatigue, cough, expectoration.